Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.6.5 has been added to the page history, replacing the previous v3.6.4. This signals a minor software/version update to the ClinicalTrials.gov interface rather than changes to trial data or content.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.6.4 is added to the record history, and the previous revision v3.6.3 is removed. This reflects an update to the page's revision log.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedA new revision entry (v3.6.3) was added to the record history, indicating an update to the study record since the previous version (v3.6.2).SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history. The previous revision v3.6.0 was removed from the visible history.SummaryDifference0.1%

- Check60 days agoChange DetectedAdds a recruitment status 'No longer looking for participants' and records the new revision 'Revision: v3.6.0', while removing the older 'Revision: v3.5.5' entry from the history.SummaryDifference0.4%

- Check67 days agoChange DetectedA new revision entry, v3.5.5, was added to the record history, replacing the previous v3.5.4.SummaryDifference0.1%

Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.